Ads
related to: clinically significant macular edema treatment- DME FAQs
Get Answers To Frequently
Asked Questions About DME
- Download The Amsler Grid
Use This Test To Help Monitor
Your Vision Between Appointments
- Clinical Study Results
See The Results of A Clinical Study
To Learn More About This Treatment
- Resource Library
Tools To Understand Your Condition
Financial Support, and More
- Financial Assistance
Learn About Financial Support
That May Be Available To You
- Appointment Tips
Get Tips And Useful Information
To Talk To Your Specialist
- DME FAQs
Search results
Results From The WOW.Com Content Network
The causes of macular edema are numerous and different causes may be inter-related. It is commonly associated with diabetes.Chronic or uncontrolled diabetes type 2 can affect peripheral blood vessels including those of the retina which may leak fluid, blood and occasionally fats into the retina causing it to swell.
The American Academy of Ophthalmology practice guidelines recommend laser coagulation for people who have both mild to moderate nonproliferative diabetic retinopathy (NPDR) and clinically significant macular edema outside the fovea; treatment with anti-VEGF drugs is better than laser coagulation for clinically significant macular edema in the fovea. [1]
Replacement of the lens as treatment for cataract can cause pseudophakic macular edema (‘pseudophakia’ means ‘replacement lens’). This could occur as the surgery involved sometimes irritates the retina (and other parts of the eye) causing the capillaries in the retina to dilate and leak fluid into the retina.
These treatments aim for the two of the most significant complications, namely macular edema and neovascularization. [ 1 ] Systemic treatment with oral aspirin, subcutaneous Heparin, or intravenous thrombolysis have not been shown to be effective treatments for central retinal vein occlusion and for branch retinal vein occlusion no reliable ...
Comparison of Age-Related Macular Degeneration Treatments Trial: Lucentis-Avastin Trial: This two-year, multicenter clinical trial compared the effectiveness of two treatments used for AMD: Lucentis and Avastin. It showed that both treatments are equally effective in treating AMD and improving vision, whether used monthly or as needed.
Diabetic retinopathy (also known as diabetic eye disease) is a medical condition in which damage occurs to the retina due to diabetes.It is a leading cause of blindness in developed countries and one of the lead causes of sight loss in the world, even though there are many new therapies and improved treatments for helping people live with diabetes.
Ads
related to: clinically significant macular edema treatment